Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1172

2.

Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review.

Marik PE, Varon J.

Clin Cardiol. 2009 Jul;32(7):365-72. doi: 10.1002/clc.20604. Review.

3.
4.

Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials.

Grosso G, Pajak A, Marventano S, Castellano S, Galvano F, Bucolo C, Drago F, Caraci F.

PLoS One. 2014 May 7;9(5):e96905. doi: 10.1371/journal.pone.0096905. eCollection 2014.

5.

Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression.

Sublette ME, Ellis SP, Geant AL, Mann JJ.

J Clin Psychiatry. 2011 Dec;72(12):1577-84. doi: 10.4088/JCP.10m06634. Epub 2011 Sep 6.

6.

The efficacy of n-3 fatty acids DHA and EPA (fish oil) for perinatal depression.

Jans LA, Giltay EJ, Van der Does AJ.

Br J Nutr. 2010 Dec;104(11):1577-85. doi: 10.1017/S0007114510004125. Epub 2010 Nov 16. Review.

PMID:
21078211
7.

Effect of fish-oil supplementation on mental well-being in older subjects: a randomized, double-blind, placebo-controlled trial.

van de Rest O, Geleijnse JM, Kok FJ, van Staveren WA, Hoefnagels WH, Beekman AT, de Groot LC.

Am J Clin Nutr. 2008 Sep;88(3):706-13.

8.

Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder.

Mocking RJ, Harmsen I, Assies J, Koeter MW, Ruhé HG, Schene AH.

Transl Psychiatry. 2016 Mar 15;6:e756. doi: 10.1038/tp.2016.29.

9.

Ethyl-eicosapentaenoic acid for the treatment of psychological distress and depressive symptoms in middle-aged women: a double-blind, placebo-controlled, randomized clinical trial.

Lucas M, Asselin G, Mérette C, Poulin MJ, Dodin S.

Am J Clin Nutr. 2009 Feb;89(2):641-51. doi: 10.3945/ajcn.2008.26749. Epub 2008 Dec 30.

10.

A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression.

Lin PY, Huang SY, Su KP.

Biol Psychiatry. 2010 Jul 15;68(2):140-7. doi: 10.1016/j.biopsych.2010.03.018. Epub 2010 May 10.

PMID:
20452573
11.

Effects of fish-oil and folate supplementation of pregnant women on maternal and fetal plasma concentrations of docosahexaenoic acid and eicosapentaenoic acid: a European randomized multicenter trial.

Krauss-Etschmann S, Shadid R, Campoy C, Hoster E, Demmelmair H, Jiménez M, Gil A, Rivero M, Veszprémi B, Decsi T, Koletzko BV; Nutrition and Health Lifestyle (NUHEAL) Study Group.

Am J Clin Nutr. 2007 May;85(5):1392-400.

12.
14.

Use of manufactured foods enriched with fish oils as a means of increasing long-chain n-3 polyunsaturated fatty acid intake.

Lovegrove JA, Brooks CN, Murphy MC, Gould BJ, Williams CM.

Br J Nutr. 1997 Aug;78(2):223-36.

PMID:
9301413
15.

Which polyunsaturated fatty acids are active in children with attention-deficit hyperactivity disorder receiving PUFA supplementation? A fatty acid validated meta-regression analysis of randomized controlled trials.

Puri BK, Martins JG.

Prostaglandins Leukot Essent Fatty Acids. 2014 May;90(5):179-89. doi: 10.1016/j.plefa.2014.01.004. Epub 2014 Feb 3. Review.

PMID:
24560325
16.

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.

17.

Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression.

Sarris J, Mischoulon D, Schweitzer I.

J Clin Psychiatry. 2012 Jan;73(1):81-6. doi: 10.4088/JCP.10r06710. Epub 2011 Aug 9.

PMID:
21903025
18.

Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients--a pilot study.

Saifullah A, Watkins BA, Saha C, Li Y, Moe SM, Friedman AN.

Nephrol Dial Transplant. 2007 Dec;22(12):3561-7. Epub 2007 Jul 10.

PMID:
17623719
19.

Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms.

Freund-Levi Y, Basun H, Cederholm T, Faxén-Irving G, Garlind A, Grut M, Vedin I, Palmblad J, Wahlund LO, Eriksdotter-Jönhagen M.

Int J Geriatr Psychiatry. 2008 Feb;23(2):161-9.

PMID:
17582225
20.

Eicosapentaenoic acid versus docosahexaenoic acid in mild-to-moderate depression: a randomized, double-blind, placebo-controlled trial.

Mozaffari-Khosravi H, Yassini-Ardakani M, Karamati M, Shariati-Bafghi SE.

Eur Neuropsychopharmacol. 2013 Jul;23(7):636-44. doi: 10.1016/j.euroneuro.2012.08.003. Epub 2012 Aug 19.

PMID:
22910528

Supplemental Content

Support Center